down arrow

National Health Investors, Inc.

  • Market Cap: Small Cap
  • Industry: Realty
  • ISIN: US63633D1046
USD
77.00
0.41 (0.54%)

Dec 24

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

76.2877.15

52 Week

65.1380.56
Valuation
Technical
Day's Volume

CASH

23.79 k

Shareholding (Mar 2025)

FII

11.18%

Held by 115 FIIs

DII

54.77%

Held by 38 DIIs

Promoter

0.00%

How big is National Health Investors, Inc.?

22-Jun-2025

As of Jun 18, National Health Investors, Inc. has a market capitalization of $3.30 billion, with net sales of $345.86 million and a net profit of $139.80 million over the last four quarters.

Market Cap: As of Jun 18, National Health Investors, Inc. has a market capitalization of 3,299.84 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported net sales of 345.86 million and a net profit of 139.80 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,366.47 million and total assets of 2,614.37 million.

Read More

What does National Health Investors, Inc. do?

22-Jun-2025

National Health Investors, Inc. is a self-managed REIT focused on financing senior housing and medical investments, with a market cap of approximately $3.3 billion. As of March 2025, it reported net sales of $90 million and a net profit of $34 million.

Overview:<BR>National Health Investors, Inc. is a self-managed real estate investment trust (REIT) specializing in the financing of senior housing and medical investments within the realty industry, categorized as a small-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 90 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 34 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 3,299.84 Million (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 23.00 <BR>Dividend Yield: 473.58% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 10.44% <BR>Price to Book: 2.31<BR><BR>Contact Details:<BR>Address: 222 Robert Rose Dr, MURFREESBORO TN: 37129-6346 <BR>Tel: 1 615 8909100 <BR>Website: http://www.nhireit.com

Read More

Who are in the management team of National Health Investors, Inc.?

22-Jun-2025

As of March 2022, the management team of National Health Investors, Inc. includes Independent Chairman Mr. W. Andrew Adams and Independent Directors Mr. James Jobe, Mr. Robert McCabe, and Mr. Robert Webb.

As of March 2022, the management team of National Health Investors, Inc. includes Mr. W. Andrew Adams, who serves as the Independent Chairman of the Board, along with Mr. James Jobe, Mr. Robert McCabe, and Mr. Robert Webb, all of whom are Independent Directors.

Read More

Is National Health Investors, Inc. overvalued or undervalued?

20-Sep-2025

As of August 27, 2025, National Health Investors, Inc. is considered very attractive due to its undervalued status reflected in a P/E ratio of 23, a competitive EV to EBITDA ratio of 12.07, a solid ROCE of 14.97%, and a high dividend yield of 461.57%, despite recent underperformance compared to the S&P 500.

As of 27 August 2025, the valuation grade for National Health Investors, Inc. has moved from attractive to very attractive, indicating a strong positive shift in its valuation outlook. The company appears to be undervalued, particularly when considering its P/E ratio of 23, which is lower than the peer average of approximately 24.77, and an EV to EBITDA ratio of 12.07, also competitive against peers like Broadstone Net Lease, Inc. at 9.17. Additionally, the PEG ratio of 4.40 suggests that while growth expectations may be high, the current price does not fully reflect the potential growth of the company.<BR><BR>In comparison to its peers, National Health Investors, Inc. stands out with a solid ROCE of 14.97% and a dividend yield of 461.57%, which is significantly attractive in the current market. Notably, while the company has underperformed the S&P 500 over the past year with a return of -6.95% compared to 17.14%, it has shown resilience with a 3-year return of 26.85%, although it lags behind the S&P 500's 70.41% return during the same period. This combination of valuation metrics and peer comparisons suggests that National Health Investors, Inc. is positioned well for future growth, reinforcing its undervalued status.

Read More

Is National Health Investors, Inc. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, National Health Investors, Inc. shows a bullish technical trend supported by strong weekly indicators, despite mixed monthly signals, with a one-month return of 5.80% compared to the S&P 500's 2.33%.

As of 8 September 2025, the technical trend for National Health Investors, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supporting the positive trend, while the monthly MACD is mildly bearish, indicating some caution. The weekly RSI is bearish, but the daily moving averages are bullish, reinforcing the overall bullish stance. Bollinger Bands are bullish on both weekly and monthly time frames. The KST is bullish weekly but mildly bearish monthly, and Dow Theory shows a mildly bullish stance on both time frames. <BR><BR>In terms of performance, the stock has returned 5.80% over the past month compared to 2.33% for the S&P 500, and it has a year-to-date return of 14.33% versus 12.22% for the benchmark. However, the one-year return is negative at -6.95%, while the S&P 500 has gained 17.14%. Overall, the current technical stance is bullish, driven by strong weekly indicators despite some mixed signals in the monthly data.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 9.57%

 
2

Poor long term growth as Operating profit has grown by an annual rate of -3.24%

 
3

Flat results in Jun 25

4

With ROE of 10.44%, it has a fair valuation with a 2.37 Price to Book Value

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 3,727 Million (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

419.29%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

10.17%

stock-summary
Price to Book

2.52

Revenue and Profits:
Net Sales:
91 Million
(Quarterly Results - Jun 2025)
Net Profit:
37 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.11%
0%
-3.11%
6 Months
6.94%
0%
6.94%
1 Year
10.98%
0%
10.98%
2 Years
35.42%
0%
35.42%
3 Years
42.38%
0%
42.38%
4 Years
37.5%
0%
37.5%
5 Years
10.46%
0%
10.46%

National Health Investors, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.42%
EBIT Growth (5y)
-3.24%
EBIT to Interest (avg)
5.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
115.16%
Pledged Shares
0
Institutional Holding
74.42%
ROCE (avg)
13.88%
ROE (avg)
9.57%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
2.37
EV to EBIT
16.81
EV to EBITDA
12.07
EV to Capital Employed
2.52
EV to Sales
9.40
PEG Ratio
4.40
Dividend Yield
461.57%
ROCE (Latest)
14.97%
ROE (Latest)
10.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 66 Schemes (33.98%)

Foreign Institutions

Held by 115 Foreign Institutions (11.18%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.56% vs 4.05% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 8.58% vs -21.03% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "91.40",
          "val2": "90.00",
          "chgp": "1.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "71.70",
          "val2": "69.20",
          "chgp": "3.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.00",
          "val2": "14.30",
          "chgp": "4.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.00",
          "val2": "-1.70",
          "chgp": "41.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "36.70",
          "val2": "33.80",
          "chgp": "8.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "558.80%",
          "val2": "547.70%",
          "chgp": "1.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.87% vs 12.85% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.64% vs 105.19% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "338.10",
          "val2": "322.40",
          "chgp": "4.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "263.90",
          "val2": "251.50",
          "chgp": "4.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "59.90",
          "val2": "58.20",
          "chgp": "2.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.30",
          "val2": "-1.90",
          "chgp": "-231.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "136.60",
          "val2": "134.40",
          "chgp": "1.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "560.70%",
          "val2": "555.30%",
          "chgp": "0.54%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
91.40
90.00
1.56%
Operating Profit (PBDIT) excl Other Income
71.70
69.20
3.61%
Interest
15.00
14.30
4.90%
Exceptional Items
-1.00
-1.70
41.18%
Consolidate Net Profit
36.70
33.80
8.58%
Operating Profit Margin (Excl OI)
558.80%
547.70%
1.11%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.56% vs 4.05% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 8.58% vs -21.03% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
338.10
322.40
4.87%
Operating Profit (PBDIT) excl Other Income
263.90
251.50
4.93%
Interest
59.90
58.20
2.92%
Exceptional Items
-6.30
-1.90
-231.58%
Consolidate Net Profit
136.60
134.40
1.64%
Operating Profit Margin (Excl OI)
560.70%
555.30%
0.54%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 4.87% vs 12.85% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.64% vs 105.19% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About National Health Investors, Inc. stock-summary
stock-summary
National Health Investors, Inc.
Realty
National Health Investors, Inc. is a self-managed real estate investment trust (REIT). The Company is specialized in the sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. The Company manages approximately 236 properties in over 34 states. The senior housing in its portfolio are either need-driven or discretionary for end users and consist of independent living facilities, assisted living facilities, senior living campuses, and entrance-fee communities. The medical facilities within its portfolio consist of skilled nursing facilities, hospitals and medical office buildings.
Company Coordinates stock-summary
Company Details
222 Robert Rose Dr , MURFREESBORO TN : 37129-6346
stock-summary
Tel: 1 615 8909100
stock-summary
http://www.nhireit.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."